Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Davidson

Showing results (161-170 of 815) with videos related to

Pageof 82
Sort By:
Diabetes Care|November 24, 2011
Comment on: Hellemons et al. Initial angiotensin receptor blockade-induced decrease in albuminuria is associated with long-term renal outcome in type 2 diabetic patients with microalbuminuria: a post hoc analysis of the IRMA-2 trial. Diabetes Care 2011;34:2078-2083Mayer B Davidson
Diabetes Care|September 1, 1995
Response to NathanM B Davidson
Diabetes|March 2, 2002
Status of research funded by the American Diabetes Association: year 3Mayer B Davidson
Diabetologia|October 16, 2016
Diabetic retinopathy is not present in newly diagnosed diabetic patientsMayer B Davidson
Diabetes, Obesity & Metabolism|March 3, 2020
Second-generation basal insulins to initiate insulin therapy in type 2 diabetes: A need for clinical evidence before incurring increased costsMayer B Davidson
The Western Journal of Medicine|September 1, 1978
The case for control in diabetes mellitusM B Davidson
The American Journal of the Medical Sciences|July 1, 1986
Pathogenesis of type 2 diabetes mellitus: an interpretation of current dataM B Davidson
Annals of Internal Medicine|April 16, 2019
Review: Rapid-acting analogues do not differ from regular human insulin for mortality or HbA1c in type 2 diabetesMayer B Davidson
Diabetes Research and Clinical Practice|February 8, 2022
Historical review of the diagnosis of prediabetes/intermediate hyperglycemia: Case for the international criteriaMayer B Davidson
Diabetes Care|March 29, 2022
Comment on Aleppo et al. The Effect of Discontinuing Continuous Monitoring in Adults With Type 2 Diabetes Treated With Basal Insulin. Diabetes Care 2021;44:2729-2737Mayer B Davidson
Pageof 82

Showing results (161-170 of 815) with videos related to

Sort By:
Pageof 82
Diabetes Care|November 24, 2011
Comment on: Hellemons et al. Initial angiotensin receptor blockade-induced decrease in albuminuria is associated with long-term renal outcome in type 2 diabetic patients with microalbuminuria: a post hoc analysis of the IRMA-2 trial. Diabetes Care 2011;34:2078-2083Mayer B Davidson
Diabetes Care|September 1, 1995
Response to NathanM B Davidson
Diabetes|March 2, 2002
Status of research funded by the American Diabetes Association: year 3Mayer B Davidson
Diabetologia|October 16, 2016
Diabetic retinopathy is not present in newly diagnosed diabetic patientsMayer B Davidson
Diabetes, Obesity & Metabolism|March 3, 2020
Second-generation basal insulins to initiate insulin therapy in type 2 diabetes: A need for clinical evidence before incurring increased costsMayer B Davidson
The Western Journal of Medicine|September 1, 1978
The case for control in diabetes mellitusM B Davidson
The American Journal of the Medical Sciences|July 1, 1986
Pathogenesis of type 2 diabetes mellitus: an interpretation of current dataM B Davidson
Annals of Internal Medicine|April 16, 2019
Review: Rapid-acting analogues do not differ from regular human insulin for mortality or HbA1c in type 2 diabetesMayer B Davidson
Diabetes Research and Clinical Practice|February 8, 2022
Historical review of the diagnosis of prediabetes/intermediate hyperglycemia: Case for the international criteriaMayer B Davidson
Diabetes Care|March 29, 2022
Comment on Aleppo et al. The Effect of Discontinuing Continuous Monitoring in Adults With Type 2 Diabetes Treated With Basal Insulin. Diabetes Care 2021;44:2729-2737Mayer B Davidson
Pageof 82